Table 1.
FDA-Approved Fluorinated (F-18) Radiolabeled Drugs.
| Name | Structure | Mode of Action/Uses | References |
|---|---|---|---|
| Flortaucipir F-18 |
|
Small lipophilic tracer containing 18F capable of crossing the blood–brain barrier and binding to aggregated tau proteins; used in PET imaging for the diagnosis of Alzheimer’s disease. | [43] |
| Fluciclovine F-18 |
|
Transported into prostate cancer cells via ASCT2 and LAT1 transporters. | [44] |
| Fluorodopa F-18 |
|
Decarboxylated by aromatic amino acid decarboxylase (AADC) in the striatum to fluorodopa F-18. Fluorodopa F-18 is then further metabolized by monoamine oxidase (MAO) to yield 18F 6-fluoro-3,4-dihydroxyphenylacetic acid. | [45] |
| Fluoroestradiol F-18 |
|
Radioactive diagnostic agent for the detection of estrogen receptor-positive lesions. | [46] |
| Piflufolastat F-18 |
|
Binds to PSMA and allows for the visualization of PSMA-positive lesions associated with prostate cancer. | [47] |